Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug delivery
Abstract:
The invention provides ocular formulations and features a nano-emulsion composition, e.g., a nano-emulsion comprising a CBFβ-RUNX1 inhibitor. The composition comprises a particle with a length of less than 200 nanometers in at least one dimension.
Public/Granted literature
Information query
Patent Agency Ranking
0/0